Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

45results about How to "Increased mortality" patented technology

Preparation and application of dsMpC002-coated ZIF-8 nano-composite

The invention relates to the technical field of biology, and particularly provides preparation and application of a dsMpC002-coated ZIF-8 nano complex. According to the invention, a green peach aphid effector dsMpC002 is taken as a target, a ZIF-8 delivery system of the green peach aphid effector dsMpC002 with a stable superexcellent target is constructed, and a dsMpC002-ZIF-8 nano-composite is prepared and obtained. By observing and analyzing the MpC002 gene expression quantity, the death rate and the single female farrowing quantity of the green peach aphid after the pepper variety DYJ sprayed with the dsMpC002-coated ZIF-8 nano-complex with different concentrations is fed, the control effect of the dsMpC002-coated ZIF-8 nano-complex on the green peach aphid is determined. And a new target technology and a new idea are provided for innovating an aphid control method.
Owner:SANYA RES INST OF CHINESE ACAD OF TROPICAL AGRI +1

Application of LGG exosome in preparation of medicine for preventing and treating sepsis acute lung injury

The invention relates to the field of acute lung injury caused by sepsis, in particular to application of lactobacillus rhamnosus exosome in preparation of medicine for treating and / or preventing acute lung injury caused by sepsis of subjects, and the acute lung injury caused by sepsis is acute complication of sepsis. The sepsis is caused by bacterial infection, and the particle size of the lactobacillus rhamnosus exosome ranges from 50 nm to 120 nm. The lactobacillus rhamnosus exosome provided by the invention can prevent and / or timely and effectively prevent the development of the disease course of a subject at the initial stage of sepsis acute lung injury, and finally, the treatment success rate of the subject is increased, and the prognosis of the subject is improved.
Owner:成都市第五人民医院

Mortierella chlamydosporia and application thereof

ActiveCN119614390Ahigh fatality rateincreased mortalityBiocideFungiBiotechnologyMicroorganism
The invention relates to the technical field of biological control, and discloses a hyphantria cunea biocontrol bacterium and application thereof, the biocontrol bacterium is classified and named as Entomortierella chlamydosporella chlamydosporella chlamydosporella chlamydosporella chlamydosporella chlamydosporella chlamydosporella chlamydosporella chlamydosporella chlamydosporella chlamydosporella chlamydosporella chlamydosporella chlamydosporella chlamydosporella chlamydosporella chlamydosporella chlamydosporella chlamydosporella The hyphantria cunea biocontrol bacterium strain provided by the invention can obviously inhibit the survival activity of hyphantria cunea, the death rate of hyphantria cunea larvae can be increased to 96.7% after 7 days of treatment, and the hyphantria cunea larvae can die in the pupal stage and cannot be subjected to eclosion, so that the hyphantria cunea biocontrol bacterium strain can be used for preventing and treating hyphantria cunea, is typical biological prevention and treatment, can avoid the problems of drug resistance, environmental pollution and the like caused by chemical prevention and treatment, and has broad application prospects. Good application prospects are realized.
Owner:JIANGSU POLYTECHNIC COLLEGE OF AGRI & FORESTRY

Method for evaluating risk of acute cerebral vascular disease using soluble clec2

PendingEP4350349A4reduce probabilityincreased mortalityDisease diagnosisBiological testing
Provided is a convenient, rapid, and objective blood test-based risk evaluation method for the diagnosis of TIA that can complement the clinical symptom interview, and provided is a convenient, rapid, and objective blood test-based risk evaluation method for the differential diagnosis of cardiogenic and non-cardiogenic acute cerebral vascular diseases such as cerebral infarction and TIA that can complement imaging, electrocardiogram, and conventional blood tests. The concentration of soluble CLEC2 is measured in the blood collected from a patient.
Owner:PHC CORP

Method for realizing target gene editing of prawn offspring by exopalaemon carinicauda or vannabine

The invention relates to a method for editing target genes of prawn filial generations by exopalaemon carinicauda or vannabine and application of the method. Based on the gonad development and reproduction characteristics of shrimps and crabs, Cas9 RNP (a mixture formed by mixing sgRNA and Cas9 ribonucleoprotein) is directly injected into bodies of exopalaemon carinicauda or litopenaeus vannamei with developed ovaries in an intramuscular injection manner. The used sgRNA is a guide RNA (Ribonucleic Acid), namely EcIAG-gRNA or LvIAG-gRNA, which is designed on the basis of an IAG gene (EcIAG or LvIAG) of exopalaemon carinicauda or litopenaeus vannamei. Different gRNAs and Cas9 proteins are respectively mixed and then injected into an exopalaemon carinicauda or litopenaeus vannamei parent body through intramuscular injection, Cas9 RNP can enter an ovary along with blood circulation and enter an oocyte along with development of the ovary, editing of a target gene on a genome is realized, and after the edited oocyte develops into an ovum, a progeny edited mutant is formed through fertilization. The method can also be used for delivering other biological macromolecular substances to oocytes of decapod crustacean such as exopalaemon carinicauda or litopenaeus vannamei.
Owner:INST OF OCEANOLOGY - CHINESE ACAD OF SCI

Device for accelerating cell resuscitation in batches

The invention relates to the technical field of cell resuscitation devices, in particular to a batch acceleration cell resuscitation device which comprises a mounting base, a resuscitation box is arranged on the mounting base, and a batch resuscitation mechanism for simultaneously performing water bath heating on a plurality of cryopreservation tube bodies is arranged in the resuscitation box. A water bath heating mechanism is arranged on the inner side wall of the resuscitation box body, an automatic feeding mechanism is arranged at the upper end of the batch resuscitation mechanism, a resuscitation auxiliary mechanism for disinfecting the outer surfaces of the cryopreservation tubes is arranged at the upper end of the resuscitation box body, and the automatic feeding mechanism comprises a rectangular convex block movably mounted on a mounting disc. The automatic feeding mechanism is arranged, the feeding hopper and the L-shaped pushing plate are matched with each other, the cryopreservation pipe body is always in a horizontal state in the feeding process, liquid nitrogen in the external rotation cryopreservation pipe can automatically flow out before water bath heating, and the cryopreservation pipe can be prevented from exploding in the water bath heating process to a certain extent.
Owner:ZHONGKE (SHANDONG) MEDICAL DEVELOPMENT CO LTD

Application of epidermal protein gene SlituCP26 in prevention and treatment of prodenia litura

The invention discloses application of an epidermal protein gene SlituCP26 in prevention and treatment of prodenia litura, and relates to the technical field of biology. The nucleotide sequence of the SlituCP26 gene is shown as SEQ ID NO: 1, the SlituCP26 gene is highly expressed in an indoxacarb resistant strain, dsRNA of the gene is prepared, the dsRNA is micro-injected into prodenia litura larvae, after injection, the expression level of the SlituCP26 gene is obviously reduced, the body type of the larvae is obviously reduced, the epidermis thickness is obviously reduced, and the sensitivity to indoxacarb is obviously improved. The invention also provides a SlituCP26 gene promoter, and the drug resistance of the prodenia litura can be detected through the difference in sequence after the promoter is amplified. According to the invention, the fact that the epidermal protein SlituCP26 gene participates in the effect of the prodenia litura on resisting insecticides and the formation process of a resistance mechanism is clear, and the epidermal protein SlituCP26 gene has theoretical significance on the development of new insecticides.
Owner:HUNAN AGRI UNIV

Treatment method for solidago canadensis

PendingCN119054548Aeasy to controleffective control of diffusionPlant protectionGlyphosateIsopropylamine
The invention relates to the technical field of ecological control, and particularly provides a treatment method for solidago canadensis. The treatment method provided by the invention comprises the following steps: spraying solidago canadensis in winter by adopting a glyphosate solution with the volume concentration of 1.5-2.4 mL / L, and the spraying dosage is 240-360 mL / m < 2 >; the glyphosate solution is obtained by diluting a glyphosate isopropylamine salt stock solution with the mass concentration of 41% through a solvent. By means of the treatment method, solidago canadensis can be effectively controlled, and meanwhile damage to most of associated local plants can be avoided.
Owner:RES INST OF SUBTROPICAL FORESTRY CHINESE ACAD OF FORESTRY

Yak intramuscular precursor fat immortalized cell line and preparation method thereof

The invention discloses a yak intramuscular precursor fat immortalized cell line and a preparation method thereof. The method comprises the following steps: (1) obtaining yak primary intramuscular precursor fat cells; (2) performing SV40T lentivirus infection on the precursor fat cells in the yak muscle and screening cell strains: performing SV40T lentivirus infection by utilizing a 1 / 2 small-volume infection method to obtain immortalized cells after the precursor fat cells in the yak primary muscle are infected with SV40T, namely immortalized cells for short; puromycin is adopted to screen immortalized cells; and diluting the screened cells by using a limited dilution method, and carrying out enlarged culture to obtain the immortalized cell line. The yak intramuscular precursor fat immortalized cell line constructed by the invention has genetic homogeneity, the heterogeneity influence of cell populations is eliminated, and an in-vitro cell model is provided for subsequent research related to yak intramuscular fat cells.
Owner:SOUTHWEST UNIVERSITY FOR NATIONALITIES

Enterococcus casei bacteriophage, application thereof and target bacterium pest control method

The invention discloses an enterococcus casei bacteriophage, application thereof and a target bacterium pest control method. Enterococcus casei is a kind of probiotics commonly co-generated in lepidoptera pests. The preservation name of the bacteriophage is Enterococcus cassiae phage SP-1, the preservation unit of the bacteriophage is China Center for Type Culture Collection, the preservation date of the bacteriophage is July 22, 2024, and the preservation number of the bacteriophage is CCTCC M 20241620. The bacteriophage is identified as a Caudovirus bacteriophage through genome sequencing, and the Caudovirus bacteriophage is named as SP-1. According to the technology, the carrying capacity of probiotics in pests is reduced by utilizing the targeted removal capacity of the phage on the pest probiotics, so that the prevention and treatment effect of the insecticide on the pests is improved. The technology is helpful to have further research and development and farmland application prospects in the fields of agricultural pest control, novel green biological insecticide development and the like.
Owner:WESTLAKE UNIV

Application of rapamycin in improving the mosquito-killing activity of Bacillus thuringiensis mosquito-killing toxin

ActiveCN116267963Bincreased mortalityshorten the time to deathBiocideAnimal repellants
The present invention relates to a new use of rapamycin, and in particular to the use of rapamycin in improving the mosquito-killing activity of Bacillus thuringiensis mosquito-killing toxin. The present invention is the first to apply rapamycin, an immunosuppressant in clinical medicine, to the study of microbial control of pathogenic mosquitoes, and finds that the addition of a low dose of rapamycin can significantly improve the mosquito-killing activity of Bacillus thuringiensis Cry4Ba toxin. The present invention provides an important basis for the subsequent development of new biological pesticides and related small molecule synergists, and is of great significance in improving the activity of microbial pesticides and reducing the cost of use. It also provides a new research direction for studying the insecticidal mechanism of biological control microorganisms represented by Bacillus thuringiensis.
Owner:MINJIANG UNIVERSITY

A miRNA for killing termites and a method for controlling termites in combination with green muscardine

ActiveCN118006611BEffective controlincreased mortalityBiocideAnimal repellants
The present invention discloses a miRNA for killing termites and a method for controlling termites by combining the miRNA and green muscardine. The termite control drug contains miR-571 or its agonist as an active ingredient, and the nucleotide sequence of the miR-571 is uuucuguuggugauaucugac. The present invention can effectively increase the mortality rate of termites by injecting or feeding the miR-571 agonist to termites, and injecting or feeding the miR-571 agonist to termites and spraying green muscardine, and the latter causes a higher mortality rate, which can be used as a method for controlling termites.
Owner:INST OF ZOOLOGY GUANGDONG ACAD OF SCI

Dsrna of brown planthopper gene nlugt7 and its application and method for preventing and treating brown planthopper

PendingCN122256353Aincreased mortalityBiocideAnimal repellantsBiotechnologyResistant genes
The application belongs to the field of agricultural biotechnology, and particularly relates to a dsRNA of a brown planthopper gene and application of the dsRNA in preventing and treating the brown planthopper and related methods. NlUGT7 The dsRNA of the gene is prepared through in vitro transcription, and RNA interference treatment is performed on the brown planthopper through microinjection. NlUGT7 The results show that after the dsRNA is injected, the expression amount of the gene in the brown planthopper of biotype Y and biotype 1 is significantly reduced. NlUGT7 After the gene is silenced, the survival rate of the brown planthopper of biotype Y feeding on YHY15 rice containing a Bph15 resistance gene or the brown planthopper of biotype 1 feeding on TN1 rice not containing the resistance gene is significantly reduced. NlUGT7 The gene plays an important role in the survival process of the brown planthopper, and can be used as an effective target for preventing and treating the brown planthopper. NlUGT7 The gene and the dsRNA thereof provided by the application can be applied to research and development of biological pesticides for the brown planthopper and green prevention and control, and have good application prospects.
Owner:HENAN UNIVERSITY

Application of traditional Chinese medicine composition in preparation of medicine for treating or preventing hand-foot-and-mouth disease

PendingCN119303033Aprolong the average survival timeReduce clinical symptomsAnthropod material medical ingredientsAntiviralsHand-foot-and-mouth diseaseCimicifuga foetida
The invention relates to application of a traditional Chinese medicine composition in a medicine for treating or preventing a hand-foot-and-mouth disease. The traditional Chinese medicine composition is prepared from 100 to 400 parts of honeysuckle flower, 75 to 300 parts of radix puerariae, 100 to 400 parts of fructus forsythiae, 60 to 240 parts of fructus arctii, 60 to 240 parts of herba menthae, 60 to 240 parts of radix isatidis, 75 to 300 parts of rhizoma anemarrhenae, 50 to 200 parts of rhizoma cimicifugae and 30 to 120 parts of cicada slough. The traditional Chinese medicine composition can significantly reduce the death rate of ICR suckling mice infected with hand-foot-mouth viruses, improve the death protection rate, prolong the average survival days of the suckling mice, improve and prolong the life rate, and relieve clinical disease symptoms after the suckling mice are infected.
Owner:JIANGSU KANION PHARMA CO LTD

Ampullaria gigas antifeedant based on NPFR gene and application of Ampullaria gigas antifeedant

The invention discloses an NPFR gene-based pomacea canaliculata antifeedant and application thereof, and belongs to the field of prevention and control of agricultural pests. The dsNPFR based on the NPFR gene is designed and synthesized on the basis of an RNAi-mediated NPFR gene silencing technology, by injecting the dsNPFR into the ampullaria gigas, the lethal effect is obvious, the NPFR gene expression quantity, the body weight growth rate, the leaf feeding area, the digestive enzyme activity and the like are remarkably reduced, feeding and growth of the ampullaria gigas are effectively inhibited, a new strategy and a molecular target are provided for research and development of RNAi biopesticides, and the application has a wide application prospect. And a new technical approach is provided for prevention and control of ampullaria gigas invasion hazards.
Owner:SHANGHAI ACAD OF AGRI SCI

Application of Fam198B gene or protein coded by Fam198B gene in myocardial infarction treatment

PendingCN119185592Aincreased mortalityPeptide/protein ingredientsNon-active genetic ingredientsPosterior myocardiumApoptosis
The invention belongs to the technical field of biological medicines, and particularly relates to an application of a Fam198B gene or a protein coded by the Fam198B gene in preparation of a medicine for preventing, relieving or / and treating myocardial infarction. It is found for the first time that the expression level of Fam198B in myocardial tissue of a myocardial infarction mouse induced by coronary artery ligation is remarkably increased; in addition, after myocardial infarction of the mouse with the Fam198B gene specifically knocked out of the myocardial cells is carried out for one day, the myocardial cell apoptosis is obviously increased, and the systolic function of the heart becomes poor; after 10 days of myocardial infarction of the mouse with the Fam198B gene specifically knocked out of the myocardial fibroblasts, the systolic function of the heart becomes poor, collagen secretion of the fibroblasts is increased, and the death rate of the mouse is remarkably increased. The results show that Fam198B participates in dual regulation and control of myocardial cell survival and fibroblast activation, and plays a role in heart protection in the pathological process of myocardial infarction. Therefore, the Fam198B gene, the Fam198B protein and the activator expressed by the Fam198B gene can be used for preparing the medicine for preventing, relieving or / and treating the myocardial infarction, and the Fam198B gene or the Fam198B protein can also be used as a medicine target for screening the medicine for preventing, relieving or / and treating the myocardial infarction.
Owner:THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIV

Application of medicine in improving sleep disorder

The invention belongs to the technical field of biological medicines, and particularly relates to application of an mTOR inhibitor to improvement of sleep disorders. Aiming at the defects of the existing hypnotics, the invention finds that the sleep disorder can be improved by using the Rapamycin through researching a new sleep pathway target. The Rapamycin disclosed by the invention is a non-addictive sleeping drug, and can induce natural sleep behaviors; compared with an existing clinical hypnotics which has the side effect of greatly increasing the death rate, the Rapamycin administration disclosed by the invention is beneficial to improving the sleep quality and prolonging the life of animals at the same time. The invention discloses a remarkable effect of Rapamycin in the aspect of improving the sleep disorder, and the discovery has important significance in improving the sleep quality of a patient and preventing the progress of diseases, so that the Rapamycin has a wide medical prospect and a remarkable economic value.
Owner:SHANGHAI EAST HOSPITAL EAST HOSPITAL TONGJI UNIV SCHOOL OF MEDICINE

Application of citrus psylla saliva gene DcPS2 in prevention and treatment of citrus psylla and huanglongbing

This invention provides the application of the citrus psyllid salivary gland gene DcPS2 in the control of citrus psyllids and Huanglongbing (HLB). The nucleotide sequence of the citrus psyllid salivary gland gene DcPS2 is shown in SEQ ID NO. 1. This invention introduces dsDcPS2 into psyllids and measures the effect of DcPS2 gene silencing on psyllid survival. Experimental results show that after DcPS2 gene silencing, the mortality rate of citrus psyllids significantly increased compared to the control dsGFP, which has significant value for the control of citrus psyllids and the cultivation of psyllid-resistant plants.
Owner:GANNAN NORMAL UNIV

Combined application of nuclear polyhedrosis virus and bacillus thuringiensis in preparation of preparation for preventing and treating agrotis ypsilon larvae

ActiveCN119563655Aincreased mortalitySynergistic effect is obviousBiocideAnimal repellantsNuclear Polyhedrosis VirusAgrotis ipsilon
The invention discloses combined application of nuclear polyhedrosis virus and bacillus thuringiensis in preparation of a preparation for preventing and treating black cutworm larvae, and relates to the technical field of black cutworm larva prevention and treatment. The matching experiment of different types and different concentrations of nuclear polyhedrosis viruses and bacillus thuringiensis shows that compared with single use of nuclear polyhedrosis viruses or single use of bacillus thuringiensis, the mixed combination of the nuclear polyhedrosis viruses and the bacillus thuringiensis has an obvious synergistic effect in prevention and treatment of young cutworms; the death rate of indoor and field black cutworm larvae can be remarkably increased, the prevention and treatment effect is improved, and a theoretical basis is provided for biological prevention and treatment of black cutworms. Meanwhile, the nuclear polyhedrosis virus and the bacillus thuringiensis are combined for use, so that the problem of < 3 > R caused by chemical pesticide prevention and control can be avoided from the source, and the method is environment-friendly and beneficial to long-term development.
Owner:LIUYANG BRANCH OF CHANGSHA COMPANY OF HUNAN TOBACCO

Preparation method and application of LRG1-targeted enzyme-responsive nano-drug

PendingCN119656173Aincreased mortalityImprove anti-tumor efficacyOrganic active ingredientsDigestive systemDrug conjugationDrug target
The invention provides an enzyme-responsive nano-drug targeting LRG1 protein, and belongs to the technical field of biological medicines, and the nano-drug is formed by co-assembling an amphiphilic drug conjugate and a carried hydrophobic drug. Wherein the drug conjugate comprises a hydrophilic end of ET peptide targeting LRG1 and a hydrophobic end of the cytotoxic chemotherapeutic drug, the hydrophilic end is covalently linked with the hydrophobic segment through an enzyme-responsive linker, and the hydrophobic drug is entrapped in the amphiphilic drug conjugate. The preparation method comprises the following steps: dissolving the amphipathic drug conjugate and the hydrophobic drug in an organic phase, uniformly mixing the amphipathic drug conjugate and the hydrophobic drug under an ultrasonic condition, dispersing the mixture into a water phase, and standing at room temperature to obtain the targeted response type nano-drug which can prolong the in-vivo circulation time of the drug, realize efficient targeting of a colorectal tumor part, remarkably inhibit the growth of the colorectal tumor of a mouse, and has a good application prospect. DNA damage of tumor cells is promoted, tumor cell apoptosis is induced, and an effective and accurate novel method is provided for enhancing the colorectal cancer treatment effect.
Owner:ZHENGZHOU UNIV

Chicken manure liquid fertilizer and processing technology thereof

The invention discloses a chicken manure liquid fertilizer and a processing technology thereof. The processing technology comprises the following steps: stirring and mixing fresh chicken manure and a culture solution; carrying out solid-liquid separation on the obtained mixture of the fresh chicken manure and the culture solution; carrying out emulsification treatment on the obtained liquid material; sequentially sieving the emulsified liquid material with a 60-mesh sieve and a 80-mesh sieve to obtain an undersize product and an oversize product; standing and fermenting the obtained screen underflow, and then stirring and mixing with auxiliary materials; and emulsifying the obtained mixture to obtain the liquid fertilizer. In the processing process of the chicken manure liquid fertilizer, amino acid liquid and chicken manure are uniformly mixed through mixing and stirring, so that the fermentation efficiency is improved; in the fermentation process, the activity of microorganisms generates a large amount of heat, harmful organisms such as bacteria, viruses and parasitic ova in the excrement can be effectively killed, and the death rate of roundworm ova in a finished product is higher than 98% through inspection.
Owner:XINJIANG WANKANGCHENGYI FERTILIZER CO LTD

Separation method and device for soil granular organic matters and mineral binding organic matters

PendingCN119406565Aavoid experimental errorincreased mortalityWet separationMineral bindingSoil science
The invention provides a method for separating granular organic matters and mineral binding organic matters in soil, which comprises particle size separation and density separation, and the separation of the granular organic matters and the mineral binding organic matters in the soil is realized by combining the particle size separation and the density separation. The invention discloses a separation device for soil granular organic matters and mineral binding organic matters. The separation device structurally comprises a soil-water mixing module, a screen, a wet screen monitoring module, a fine aggregate collecting box and a density grading pretreatment module, the soil-water mixing module is located above the screen and the wet screening monitoring module, and the screen is arranged between the soil-water mixing module and the wet screening monitoring module to achieve particle size grading of soil particles. The fine aggregate collecting box is located below the wet screening monitoring module, and the fine aggregate collecting box is mounted at the top of the density grading pretreatment module; according to the method, experimental errors caused by only adopting a single particle size grading method or a single density grading method are effectively avoided.
Owner:HOHAI UNIV +1

A sweet potato armyworm nuclear polyhedrosis virus AeleNPV strain and its production method and application

ActiveCN117887675Bincreased mortalitygood control effectDsDNA virusesCotton bollwormAedia leucomelas
The present invention provides a sweet potato (white spot) cutworm nuclear polyhedrosis virus AeleNPV, which is the sweet potato (white spot) cutworm nuclear polyhedrosis virus Fuzhou strain AeleNPV‑FZ, which was deposited in the China Center for Type Culture Collection on October 19, 2023, with a deposit number of CCTCC NO: V202398. The AeleNPV‑FZ virus provided by the present invention has strong virulence, has good development and application prospects, and has application value in preventing and controlling sweet potato (white spot) cutworm and cotton bollworm. The present invention also provides a method for producing AeleNPV‑FZ using sweet potato (white spot) cutworm larvae as hosts and cotton bollworm as alternative hosts.
Owner:INSTITUTE OF MICROBIOLOGY JIANGXI ACADEMY OF SCIENCES (JIANGXI INSTITUTE OF WATERSHED ECOLOGY)

A method for establishing a largemouth bass model that simulates the susceptibility of iron overload pathogens using inorganic iron.

This invention discloses a method for establishing a largemouth bass model susceptibility to iron overload pathogens using inorganic iron, belonging to the field of biotechnology. The method includes: a) after acclimatizing 4-5cm largemouth bass to a normal diet for one week, the normal diet is replaced with a FeSO4·7H2O-supplemented diet (FeSO4·7H2O supplementation amount: 800-3200 mg / kg), while the control group continues to be fed a normal diet; b) after feeding the FeSO4·7H2O-supplemented diet for 14-56 days, the mortality rate from Aeromonas hydrophila infection increases, indicating successful establishment of the largemouth bass model susceptibility to pathogens. This method for establishing a largemouth bass model susceptibility to iron overload pathogens using inorganic iron has advantages such as simple operation, high success and survival rates, good stability, and obvious pathological characteristics.
Owner:GUANGDONG LABORATORY OF SOUTHERN OCEAN SCIENCE AND ENGINEERING (GUANGZHOU) +1

Construction method of penicillin allergic sudden death animal model

The invention relates to a method for constructing a sudden penicillin allergic death animal model. The method comprises the following steps: firstly, exploring the sensitivity of different animal types to penicillin; secondly, the influence of different doses of penicillin on the severity of the anaphylactic reaction is researched, and finally, the severity of the anaphylactic reaction caused by the penicillin under different sensitization times and different excitation interval time is discussed. According to the method, animal allergy symptoms are combined, behavioral scoring (allergic reaction intensity evaluation and allergy occurrence rate and death rate calculation) is performed, change of content of IgE, IgG, HIS and beta-Hex in colon wall tissue homogenate is detected by adopting an enzyme-linked immunosorbent assay method, and lung tissue slices are subjected to HE staining, toluidine blue staining and tryptase immunohistochemical staining. According to the invention, a sudden anaphylactic death drug penicillin which is common in forensic practice is taken as a sensitizer, factors such as animal types, drug dosage and sensitization excitation times are comprehensively considered, and the sudden anaphylactic death animal model is established, so that a reliable experimental basis is provided for studying pathological and physiological mechanisms of sudden anaphylactic death and forensic diagnosis; and scientific basis and technical support are provided for forensic medicine identification.
Owner:SHANXI MEDICAL UNIV

A pharmaceutical composition of an aquaporin inhibitor combined with temozolomide for treating brain glioma and application thereof

PendingCN122516174APoor treatment effectgood treatment effect
The application belongs to the field of biological medicine, and discloses a pharmaceutical composition of water channel protein inhibitor combined with temozolomide for treating brain glioma, wherein the pharmaceutical composition comprises AQP4 inhibitor AER270 and TMZ. The application further discloses a pharmaceutical preparation comprising the above pharmaceutical composition and application of the pharmaceutical preparation in preparation of a medicine for treating brain glioma. The composition provided by the application provides an effective drug combination strategy for treating brain glioma, and it is found for the first time that AER270 and TMZ have a synergistic effect on the treatment of brain glioma.
Owner:SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY (SHANDONG PROVINCIAL HOSPITAL)

Application of hydrogel-loaded long-acting insulin receptor antagonist in establishment of gestational diabetes animal model

The invention discloses application of a hydrogel-loaded long-acting insulin receptor antagonist in establishment of a gestational diabetes animal model, 12-week-old C57BL / 6J female mice are divided into two groups, the female mice and male mice are caged and copulated in a ratio of 2: 1, and the gestational condition is observed; from 7 days of pregnancy of a C57BL / 6J female mouse, 60 nmol / kg of an insulin receptor antagonist loaded by phenylboronic acid-hyaluronic acid hydrogel is subcutaneously injected every two days, and the gestational diabetes animal model is established. Different from the characteristics of long modeling time, low success rate, high animal death rate, embryotoxicity in modeling mode, short half-life period of modeling medicine and the like of the conventional gestational diabetes mouse or rat model, the invention establishes a stable and reliable mouse model similar to human pathogenesis, the success rate is high, no obvious toxic effect is generated on a female mouse and an embryo, and the model has a good application prospect. The medicine has a long half-life period and accords with the characteristics of human gestational diabetes.
Owner:于海涛

Hyphantria cunea HcARNT and HcCncC gene dsRNA and application thereof in prevention and treatment of hyphantria cunea

The invention provides dsRNA (double-stranded ribonucleic acid) of hyphantria cunea HcARNT and HcCncC genes, wherein the full-length cDNA of the HcARNT and the full-length cDNA of the HcCncC genes are respectively as shown in SEQ ID No. 1 and SEQ ID No. 2. The dsHcARNT or the dsHcCncC can silence the expression of the HcARNT or the HcCncC of the fall webworm respectively, interfere the HcARNT gene or the HcCncC gene of the fall webworm, and can enhance the insecticidal effect of tannic acid which is a plant secondary substance. The invention also provides application of the dsRNA in prevention and treatment of fall webworms, and the timely scheme provided by the invention can reduce the use of pesticides, and has the beneficial effects of greenness, environmental protection and the like.
Owner:NANJING FORESTRY UNIV

Nano-drug with anticancer activity as well as preparation method and application of nano-drug

The embodiment of the invention relates to a nano-drug with anti-cancer activity and a preparation method and application thereof.The nano-drug comprises a titanium carbide carrier, a targeting nano-material loaded on the titanium carbide carrier, nano-gold and glucose oxidase, the titanium carbide carrier is of a two-dimensional sheet structure, and the nano-gold and the glucose oxidase are loaded on the titanium carbide carrier. The targeting nanoparticle material comprises nano manganese dioxide, human serum protein and folic acid, the human serum protein is modified on the surface of the nano manganese dioxide and is connected with folic acid molecules to form spherical particles, nanogold and manganese dioxide targeting nanoparticles are loaded on the surface of titanium carbide, glucose oxidase wraps the surface of a titanium carbide carrier, and the folic acid targeting nanoparticles are loaded on the surface of the titanium carbide carrier. The nano-drug can serve as the basic performance of a drug carrier, the cancer cell starvation treatment effect of glucose oxidase can be further improved, and the death rate of tumor cells is increased.
Owner:QUFU NORMAL UNIV

DsRNA (double-stranded ribonucleic acid) for preventing and controlling small beetles of honeycomb and application thereof

PendingCN119265195Areduced survival rateincreased mortalityBiocideAnimal repellantsHoneycombPachnoda marginata
The invention discloses dsRNA (double-stranded ribonucleic acid) for preventing and treating small beetles of honeycomb and application of the dsRNA. According to the invention, a CYP4G279 (AtCYP4G279) gene of the small beetles is taken as a target, dsRNA is designed and injected into the bodies of the small beetles, the sequence of the dsRNA is as shown in SEQ ID NO.2, and the influence on the growth and development of the small beetles is observed; the result shows that after the AtCYP4G279dsRNA is injected, the survival rate of the small beetles is reduced, and the death rate of the small beetles after eclosion development is obviously improved; the method plays an important role in the aspect of influencing insect prevention and control. The compound can be used for preparing a preparation for preventing and treating the small beetles, and has an important effect in the prevention and treatment process of the small beetles.
Owner:INST OF ZOOLOGY GUANGDONG ACAD OF SCI +1